EJMK Ventures’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
EJMK Ventures's KRYS Position: Q3 2026 in Review
EJMK Ventures sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 561 shares — an estimated $209K sold.
EJMK Ventures first reported a position in KRYS in Q2 2026 and held it in 1 quarter. The position peaked at $209K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- EJMK Ventures reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
- EJMK Ventures sold 561 Krystal Biotech shares in Q3 2026, an estimated $209K.
- EJMK Ventures first reported a position in Krystal Biotech in Q2 2026 and held it in 1 quarter.
- EJMK Ventures's Krystal Biotech position peaked at $209K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.